Her poster, titled “Rare mutation analysis using Digital PCR on QuantStudio™ 3D to verify Ion AmpliSeq Next Generation Sequencing for Cancer Research” reveals how low frequency alleles can be detected using NGS and confirmed using digital PCR, assuring target confidence.
Next generation sequencing provides unparalleled sequencing information and is slowing becoming a tool for biomarker discovery in cancer research and for understanding tumor heterogeneity in samples. It is critical that targets be confirmed and called out confidently. This research sheds light on the sensitivity and accuracy of NGS to detect low frequency mutations and for digital PCR to provide robust confirmations on rare targets even in challenging samples like cfDNA.
Feel free to download your own copy of Marion’s poster on SlideShare and ask your questions in the comments section below.